Hans Biomed Corp. | Income Statement
Fiscal year is October-September. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
20,066
21,033
23,428
29,048
39,058
Cost of Goods Sold (COGS) incl. D&A
11,811
11,453
12,804
15,719
21,124
Gross Income
8,254
9,580
10,625
13,329
17,933
SG&A Expense
4,296
5,685
5,567
7,342
7,236
EBIT
3,892
3,895
5,058
5,988
10,521
Unusual Expense
-
-
-
105
212
Non Operating Income/Expense
106
8
453
404
142
Interest Expense
-
-
6
-
248
Pretax Income
3,929
3,947
5,521
5,522
9,936
Income Tax
495
450
611
750
1,796
Consolidated Net Income
3,434
3,498
4,909
4,772
8,140
Net Income
3,434
3,498
4,909
4,625
7,828
Net Income After Extraordinaries
3,434
3,498
4,909
4,625
7,828
Net Income Available to Common
3,434
3,498
4,909
4,625
7,828
EPS (Basic)
416.00
382.00
521.00
491.00
831.00
Basic Shares Outstanding
8
9
9
9
9
EPS (Diluted)
392.10
375.83
521.32
491.13
831.24
Diluted Shares Outstanding
9
9
9
9
9
EBITDA
4,690
4,531
5,897
7,089
12,167
Other Operating Expense
67
-
-
-
176
Non-Operating Interest Income
143
60
15
43
16
Minority Interest Expense
-
-
-
147
312
About Hans Biomed
View Profile
